MIR1296 Gene

HGNC Family Non-coding RNAs
Name microRNA 1296
Description microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nReduced expression of miR‑1296 is emerging as a key contributor to tumor progression in a broad range of human malignancies. For example, in triple‐negative breast cancer, miR‑1296 dysregulation is associated with aggressive tumor behavior ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "]. In gastric cancer, down‐regulation of miR‑1296‑5p has been linked to increased cell migration and invasion through failure to repress oncogenic pathways – one study showed that loss of miR‑1296‑5p led to enhanced ERBB2/Rac1 signaling ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "], while a separate investigation demonstrated that its low expression was concomitant with up‐regulation of CDK6 and EGFR, thereby promoting proliferation and invasiveness ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "]. In hepatocellular carcinoma, underexpression of miR‑1296 appears to contribute to tumor growth and metastasis ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "]. Moreover, functional restoration of miR‑1296‑5p has been found to inhibit aggressive features in both osteosarcoma—through targeting NOTCH2 ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": "]—and glioma, where it suppresses ABL2 expression ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": "].\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its direct tumor‐suppressive roles, the activity of miR‑1296 is frequently modulated by circular RNAs that function as molecular sponges, thereby indirectly influencing key oncogenic pathways. In breast cancer, for instance, circ_0048764 sequesters miR‑1296‑5p to upregulate TRIM14 expression, which promotes cell proliferation, migration, and invasion ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": "]. Similarly, in hepatocellular carcinoma, hsa_circ_0000519 binds miR‑1296 resulting in enhanced E2F7 expression and accelerated tumor progression ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": "]. The influence of miR‑1296 is also evident in the tumor microenvironment; in gastric cancer, circSOD2 acts as a sponge to modulate the miR‑1296/STAT1 axis, thereby enhancing M1 macrophage polarization and improving cisplatin efficacy ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": "]. Moreover, circ_RPPH1 in breast cancer similarly promotes tumor growth by regulating the miR‑1296/TRIM14 signaling pathway ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": "].\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond oncologic settings, miR‑1296 holds promise as both a non‑invasive biomarker and a regulatory molecule in other pathologies. Circulating miR‑1296 is being evaluated for its diagnostic potential in nonalcoholic fatty liver disease ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": "]. In placenta accreta spectrum, miR‑1296‑5p has been shown to promote trophoblast proliferation and invasion through down‑regulation of AGGF1 and subsequent modulation of the P53 signaling pathway, thereby contributing to the pathogenesis of abnormal placentation ["}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": "].\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Binh Phan, Shahana Majid, Sarah Ursu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tumor suppressor role of microRNA-1296 in triple-negative breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.6961"}], "href": "https://doi.org/10.18632/oncotarget.6961"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26799586"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26799586"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Xia Shan, Wei Wen, Danxia Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR 1296-5p Inhibits the Migration and Invasion of Gastric Cancer Cells by Repressing ERBB2 Expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0170298"}], "href": "https://doi.org/10.1371/journal.pone.0170298"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28099468"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28099468"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Yan Jia, Lian-Mei Zhao, Han-Yu Bai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The tumor-suppressive function of miR-1296-5p by targeting EGFR and CDK6 in gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biosci Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BSR20181556"}], "href": "https://doi.org/10.1042/BSR20181556"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30530570"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30530570"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Qiuran Xu, Xin Liu, Zhikui Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12943-017-0675-y"}], "href": "https://doi.org/10.1186/s12943-017-0675-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28606154"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28606154"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Lei Wang, Kejun Hu, Yu Chao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-1296-5p suppresses the proliferation, migration, and invasion of human osteosarcoma cells by targeting NOTCH2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.29438"}], "href": "https://doi.org/10.1002/jcb.29438"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31633240"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31633240"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Gaolian Zhang, Meng Xia, Jianhui Guo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "microRNA-1296 Inhibits Glioma Cell Growth by Targeting ABL2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Technol Cancer Res Treat (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/1533033821990009"}], "href": "https://doi.org/10.1177/1533033821990009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33550941"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33550941"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Fei Xie, Yuyuan Xiong, Jiayin Yan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circular RNA circ_0048764 promotes the development of breast cancer by regulating microRNA-1296-5p/tripartite motif containing 14 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2021.1995990"}], "href": "https://doi.org/10.1080/21655979.2021.1995990"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34787066"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34787066"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Yi Liu, Hui Tang, Yaling Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circular RNA hsa_circ_0000519 contributes to angiogenesis and tumor progression in hepatocellular carcinoma through the miR-1296/E2F7 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Cell (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13577-022-00854-7"}], "href": "https://doi.org/10.1007/s13577-022-00854-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36627545"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36627545"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Bing Qu, Jiasheng Liu, Zhiyang Peng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CircSOD2 polarizes macrophages towards the M1 phenotype to alleviate cisplatin resistance in gastric cancer cells by targeting the miR-1296/STAT1 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2023.147733"}], "href": "https://doi.org/10.1016/j.gene.2023.147733"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37625563"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37625563"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Jing Jiang, Shenghong Shi, Wei Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circ_RPPH1 facilitates progression of breast cancer via miR-1296-5p/TRIM14 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Biol Ther (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15384047.2024.2360768"}], "href": "https://doi.org/10.1080/15384047.2024.2360768"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38816350"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38816350"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Fengying Yu, Xiao Wang, Haitao Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Decreased Serum miR-1296 may Serve as an Early Biomarker for the Diagnosis of Non-Alcoholic Fatty Liver Disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Lab (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7754/Clin.Lab.2019.190335"}], "href": "https://doi.org/10.7754/Clin.Lab.2019.190335"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31625373"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31625373"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Runfang Wang, Jing Zhao, Cuilian Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Decreased AGGF1 facilitates the progression of placenta accreta spectrum via mediating the P53 signaling pathway under the regulation of miR-1296-5p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Reprod Biol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.repbio.2023.100735"}], "href": "https://doi.org/10.1016/j.repbio.2023.100735"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36753931"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36753931"}]}]}]}
Synonyms MIRN1296, MIR-1296, HSA-MIR-1296
NCBI Gene ID 100302150
API
Download Associations
Predicted Functions View MIR1296's ARCHS4 Predicted Functions.
Co-expressed Genes View MIR1296's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View MIR1296's ARCHS4 Predicted Functions.

Functional Associations

MIR1296 has 214 functional associations with biological entities spanning 3 categories (molecular profile, cell line, cell type or tissue, gene, protein or microRNA) extracted from 13 datasets.

Click the + buttons to view associations for MIR1296 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR1296 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR1296 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of MIR1296 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR1296 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR1296 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR1296 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of MIR1296 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of MIR1296 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of MIR1296 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of MIR1296 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR1296 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of MIR1296 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR1296 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.